Timothy Hoey, SVP, Cancer Biology & Co-CSO at OncoMed Pharmaceuticals Inc (OMED), sold 25,526 shares at $7.64 ($195K) on 2017-01-03, disclosed to the SEC on 2017-01-05.
Open-market sale of $195k OMED by SVP, Cancer Biology & Co-CSO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.64 | 12,763 | $98K | 50.0% |
| 2 | $7.64 | 12,763 | $98K | 50.0% |
| Total | $7.64 avg | 25,526 | $195K | 100% |
| Filing → |
| TNYA | SELL | 2024-02-16 | $27K | — | Filing → |
| TNYA | SELL | 2023-08-29 | $31K | — | Filing → |
| TNYA | SELL | 2023-08-18 | $15K | — | Filing → |